Delcath Systems (NASDAQ:DCTH – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a report issued on Tuesday. A number of other equities research analysts have also recently weighed in on the company. BTIG Research increased their price target on Delcath Systems from $19.00 to $20.00 and gave the company […]
Delcath Systems, Inc. (NASDAQ:DCTH – Get Free Report) Director Rosalind Advisors, Inc. purchased 100,000 shares of the company’s stock in a transaction on Friday, November 17th. The stock was purchased at an average cost of $2.40 per share, for a total transaction of $240,000.00. Following the purchase, the director now directly owns 1,038,828 shares in […]
Cellectar Biosciences, Inc. announced that it has entered into a securities purchase agreement to issue 24,500,000 series E-1 preferred stock and warrants for the gross proceeds of up to $102.9.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Unicycive Therapeutics, Inc (UNCY) Enters Up to $130M Financing to Commercialize and Launch Investigational New Drug Renazorb streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.